-
1
-
-
34548006143
-
Localized mediastinal lymphnode hyperplasia resembling thymoma
-
Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9 (4):822-830.
-
(1956)
Cancer
, vol.9
, Issue.4
, pp. 822-830
-
-
Castleman, B.1
Iverson, L.2
Menendez, V.P.3
-
2
-
-
0015305751
-
Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations
-
Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29 (3):670-683.
-
(1972)
Cancer
, vol.29
, Issue.3
, pp. 670-683
-
-
Keller, A.R.1
Hochholzer, L.2
Castleman, B.3
-
3
-
-
0021933846
-
A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: Clinical findings and clinicopathologic correlations in 15 patients
-
Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol. 1985;3 (9):1202-1216.
-
(1985)
J Clin Oncol
, vol.3
, Issue.9
, pp. 1202-1216
-
-
Frizzera, G.1
Peterson, B.A.2
Bayrd, E.D.3
Goldman, A.4
-
4
-
-
0024459013
-
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease
-
Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood. 1989; 74 (4):1360-1367.
-
(1989)
Blood
, vol.74
, Issue.4
, pp. 1360-1367
-
-
Yoshizaki, K.1
Matsuda, T.2
Nishimoto, N.3
-
5
-
-
0029166033
-
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease
-
Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995;86 (4):1276-1280.
-
(1995)
Blood
, vol.86
, Issue.4
, pp. 1276-1280
-
-
Soulier, J.1
Grollet, L.2
Oksenhendler, E.3
-
6
-
-
0035313167
-
Kaposi sarcomaassociated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders
-
Du MQ, Liu H, Diss TC, et al. Kaposi sarcomaassociated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood. 2001;97 (7):2130-2136.
-
(2001)
Blood
, vol.97
, Issue.7
, pp. 2130-2136
-
-
Du, M.Q.1
Liu, H.2
Diss, T.C.3
-
7
-
-
67849111384
-
HIV-associated multicentric Castleman disease
-
Oksenhendler E. HIV-associated multicentric Castleman disease. Curr Opin HIV AIDS. 2009; 4 (1):16-21.
-
(2009)
Curr opin hiv aids
, vol.4
, Issue.1
, pp. 16-21
-
-
Oksenhendler, E.1
-
8
-
-
79959300575
-
Clinical features and outcome in HIV-Associated multicentric castleman's disease
-
Bower M, Newsom-Davis T, Naresh K, et al. Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease. J Clin Oncol. 2011;29 (18):2481-2486.
-
(2011)
J Clin Oncol
, vol.29
, Issue.18
, pp. 2481-2486
-
-
Bower, M.1
Newsom-Davis, T.2
Naresh, K.3
-
9
-
-
0030680299
-
Expression of a virus-derived cytokine, KSHV vIL- 6, in HIV-seronegative Castleman's disease
-
Parravicini C, Corbellino M, Paulli M, et al. Expression of a virus-derived cytokine, KSHV vIL- 6, in HIV-seronegative Castleman's disease. Am J Pathol. 1997;151 (6):1517-1522.
-
(1997)
Am J Pathol
, vol.151
, Issue.6
, pp. 1517-1522
-
-
Parravicini, C.1
Corbellino, M.2
Paulli, M.3
-
10
-
-
0032421692
-
Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma
-
Teruya-Feldstein J, Zauber P, Setsuda JE, et al. Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma. Lab Invest. 1998; 78 (12):1637-1642.
-
(1998)
Lab Invest
, vol.78
, Issue.12
, pp. 1637-1642
-
-
Teruya-Feldstein, J.1
Zauber, P.2
Setsuda, J.E.3
-
11
-
-
9044231359
-
Multicentric Castleman's disease in HIV infection: A clinical and pathological study of 20 patients
-
Oksenhendler E, Duarte M, Soulier J, et al. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS. 1996;10 (1):61-67.
-
(1996)
AIDS
, vol.10
, Issue.1
, pp. 61-67
-
-
Oksenhendler, E.1
Duarte, M.2
Soulier, J.3
-
12
-
-
0029069445
-
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
-
Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332 (18):1186-1191.
-
(1995)
N Engl J Med
, vol.332
, Issue.18
, pp. 1186-1191
-
-
Cesarman, E.1
Chang, Y.2
Moore, P.S.3
Said, J.W.4
Knowles, D.M.5
-
13
-
-
0028588064
-
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
-
Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266 (5192):1865-1869.
-
(1994)
Science
, vol.266
, Issue.5192
, pp. 1865-1869
-
-
Chang, Y.1
Cesarman, E.2
Pessin, M.S.3
-
14
-
-
0029655296
-
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae
-
Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol. 1996; 70 (1):549-558.
-
(1996)
J Virol
, vol.70
, Issue.1
, pp. 549-558
-
-
Moore, P.S.1
Gao, S.J.2
Dominguez, G.3
-
15
-
-
0031635951
-
Kaposi's sarcomaassociated herpesvirus-encoded oncogenes and oncogenesis
-
Moore PS, Chang Y. Kaposi's sarcomaassociated herpesvirus-encoded oncogenes and oncogenesis. J Natl Cancer Inst Monogr. 1998;23: 65-71.
-
(1998)
J Natl Cancer Inst Monogr
, vol.23
, pp. 65-71
-
-
Moore, P.S.1
Chang, Y.2
-
16
-
-
0032899921
-
Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
-
Staskus KA, Sun R, Miller G, et al. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol. 1999;73 (5):4181-4187.
-
(1999)
J Virol
, vol.73
, Issue.5
, pp. 4181-4187
-
-
Staskus, K.A.1
Sun, R.2
Miller, G.3
-
17
-
-
0032978967
-
Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression
-
Sun R, Lin SF, Staskus K, et al. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol. 1999;73 (3):2232-2242.
-
(1999)
J Virol
, vol.73
, Issue.3
, pp. 2232-2242
-
-
Sun, R.1
Lin, S.F.2
Staskus, K.3
-
18
-
-
0035167125
-
Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays
-
Jenner RG, Albà MM, Boshoff C, Kellam P. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol. 2001;75 (2):891-902.
-
(2001)
J Virol
, vol.75
, Issue.2
, pp. 891-902
-
-
Jenner, R.G.1
Albà, M.M.2
Boshoff, C.3
Kellam, P.4
-
19
-
-
0035027712
-
Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus)
-
Paulose-Murphy M, Ha NK, Xiang C, et al. Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J Virol. 2001;75 (10):4843-4853.
-
(2001)
J Virol
, vol.75
, Issue.10
, pp. 4843-4853
-
-
Paulose-Murphy, M.1
Ha, N.K.2
Xiang, C.3
-
20
-
-
0031883550
-
Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)
-
Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol. 1998;72 (2): 1005-1012.
-
(1998)
J Virol
, vol.72
, Issue.2
, pp. 1005-1012
-
-
Sarid, R.1
Flore, O.2
Bohenzky, R.A.3
Chang, Y.4
Moore, P.S.5
-
21
-
-
0033599006
-
P53 inhibition by the LANA protein of KSHV protects against cell death
-
Friborg J Jr, Kong W, Hottiger MO, Nabel GJ. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature. 1999;402 (6764): 889-894.
-
(1999)
Nature
, vol.402
, Issue.6764
, pp. 889-894
-
-
Friborg Jr., J.1
Kong, W.2
Hottiger, M.O.3
Nabel, G.J.4
-
22
-
-
0030771974
-
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines
-
Boshoff C, Endo Y, Collins PD, et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science. 1997;278 (5336):290-294.
-
(1997)
Science
, vol.278
, Issue.5336
, pp. 290-294
-
-
Boshoff, C.1
Endo, Y.2
Collins, P.D.3
-
23
-
-
0029798249
-
Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma
-
Cesarman E, Nador RG, Bai F, et al. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol. 1996;70 (11): 8218-8223.
-
(1996)
J Virol.
, vol.70
, Issue.11
, pp. 8218-8223
-
-
Cesarman, E.1
Nador, R.G.2
Bai, F.3
-
24
-
-
0029837991
-
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV
-
Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 1996;274 (5293):1739-1744.
-
(1996)
Science
, vol.274
, Issue.5293
, pp. 1739-1744
-
-
Moore, P.S.1
Boshoff, C.2
Weiss, R.A.3
Chang, Y.4
-
25
-
-
0031060368
-
Human herpesvirus 8 encodes a homolog of interleukin-6
-
Neipel F, Albrecht JC, Ensser A, et al. Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol. 1997;71 (1):839-842.
-
(1997)
J Virol
, vol.71
, Issue.1
, pp. 839-842
-
-
Neipel, F.1
Albrecht, J.C.2
Ensser, A.3
-
26
-
-
0030852894
-
Kaposi's sarcoma-associated herpesvirusencoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit
-
Molden J, Chang Y, You Y, Moore PS, Goldsmith MA. A Kaposi's sarcoma-associated herpesvirusencoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem. 1997;272 (31):19625-19631.
-
(1997)
J Biol Chem
, vol.272
, Issue.31
, pp. 19625-19631
-
-
Molden, J.1
Chang, Y.2
You, Y.3
Moore, P.S.4
Goldsmith, M.A.A.5
-
27
-
-
33750316901
-
Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6
-
Hu F, Nicholas J. Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6. J Virol. 2006; 80 (21):10874-10878.
-
(2006)
J Virol
, vol.80
, Issue.21
, pp. 10874-10878
-
-
Hu, F.1
Nicholas, J.2
-
28
-
-
58149526804
-
Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6
-
Chen D, Sandford G, Nicholas J. Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6. J Virol. 2009;83 (2): 722-733.
-
(2009)
J Virol
, vol.83
, Issue.2
, pp. 722-733
-
-
Chen, D.1
Sandford, G.2
Nicholas, J.3
-
29
-
-
0032703834
-
KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways
-
Osborne J, Moore PS, Chang Y. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol. 1999;60 (10):921-927.
-
(1999)
Hum Immunol
, vol.60
, Issue.10
, pp. 921-927
-
-
Osborne, J.1
Moore, P.S.2
Chang, Y.3
-
30
-
-
74949116731
-
Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes
-
Qin Z, Kearney P, Plaisance K, Parsons CH. Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J Leukoc Biol. 2010;87 (1):25-34.
-
(2010)
J Leukoc Biol
, vol.87
, Issue.1
, pp. 25-34
-
-
Qin, Z.1
Kearney, P.2
Plaisance, K.3
Parsons, C.H.4
-
31
-
-
0032857038
-
Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells
-
Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosato G. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood. 1999;94 (8):2871-2879.
-
(1999)
Blood
, vol.94
, Issue.8
, pp. 2871-2879
-
-
Jones, K.D.1
Aoki, Y.2
Chang, Y.3
Moore, P.S.4
Yarchoan, R.5
Tosato, G.6
-
32
-
-
68849122422
-
Castleman disease: An update on classification and the spectrum of associated lesions
-
Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009;16 (4): 236-246.
-
(2009)
Adv Anat Pathol
, vol.16
, Issue.4
, pp. 236-246
-
-
Cronin, D.M.1
Warnke, R.A.2
-
33
-
-
54949105419
-
Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV1 multicentric Castleman disease (MCD)
-
Chadburn A, Hyjek EM, Tam W, et al. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV1 multicentric Castleman disease (MCD). Histopathology. 2008;53 (5):513-524.
-
(2008)
Histopathology
, vol.53
, Issue.5
, pp. 513-524
-
-
Chadburn, A.1
Hyjek, E.M.2
Tam, W.3
-
34
-
-
69549138179
-
CD20 expression in the HHV-8-infected lymphoid cells in multicentric Castleman disease
-
Naresh KN, Trivedi P, Horncastle D, Bower M. CD20 expression in the HHV-8-infected lymphoid cells in multicentric Castleman disease. Histopathology. 2009;55 (3):358-359.
-
(2009)
Histopathology
, vol.55
, Issue.3
, pp. 358-359
-
-
Naresh, K.N.1
Trivedi, P.2
Horncastle, D.3
Bower, M.4
-
35
-
-
27144488346
-
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease
-
Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood. 2005;106 (8):2627-2632.
-
(2005)
Blood
, vol.106
, Issue.8
, pp. 2627-2632
-
-
Nishimoto, N.1
Kanakura, Y.2
Aozasa, K.3
-
36
-
-
0033959608
-
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
-
Nishimoto N, Sasai M, Shima Y, et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood. 2000;95 (1):56-61.
-
(2000)
Blood
, vol.95
, Issue.1
, pp. 56-61
-
-
Nishimoto, N.1
Sasai, M.2
Shima, Y.3
-
37
-
-
0025183151
-
Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice
-
Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest. 1990;86 (2):592-599.
-
(1990)
J Clin Invest
, vol.86
, Issue.2
, pp. 592-599
-
-
Brandt, S.J.1
Bodine, D.M.2
Dunbar, C.E.3
Nienhuis, A.W.4
-
38
-
-
0034108527
-
Kaposi's sarcomaassociated herpesvirus-encoded interleukin-6
-
Aoki Y, Jones KD, Tosato G. Kaposi's sarcomaassociated herpesvirus-encoded interleukin-6. J Hematother Stem Cell Res. 2000;9 (2):137-145.
-
(2000)
J Hematother Stem Cell Res
, vol.9
, Issue.2
, pp. 137-145
-
-
Aoki, Y.1
Jones, K.D.2
Tosato, G.3
-
39
-
-
0035871682
-
Serum viral interleukin-6 in AIDS-related multicentric Castleman disease
-
Aoki Y, Tosato G, Fonville TW, Pittaluga S. Serum viral interleukin-6 in AIDS-related multicentric Castleman disease. Blood. 2001; 97 (8):2526-2527.
-
(2001)
Blood
, vol.97
, Issue.8
, pp. 2526-2527
-
-
Aoki, Y.1
Tosato, G.2
Fonville, T.W.3
Pittaluga, S.4
-
40
-
-
66549100751
-
Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease
-
Bower M, Veraitch O, Szydlo R, et al. Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease. Blood. 2009;113 (19):4521-4524.
-
(2009)
Blood
, vol.113
, Issue.19
, pp. 4521-4524
-
-
Bower, M.1
Veraitch, O.2
Szydlo, R.3
-
41
-
-
0034665781
-
High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients
-
Oksenhendler E, Carcelain G, Aoki Y, et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood. 2000;96 (6):2069-2073.
-
(2000)
Blood
, vol.96
, Issue.6
, pp. 2069-2073
-
-
Oksenhendler, E.1
Carcelain, G.2
Aoki, Y.3
-
42
-
-
1842312491
-
Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells
-
Grandadam M, Dupin N, Calvez V, et al. Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells. J Infect Dis. 1997; 175 (5):1198-1201.
-
(1997)
J Infect Dis
, vol.175
, Issue.5
, pp. 1198-1201
-
-
Grandadam, M.1
Dupin, N.2
Calvez, V.3
-
43
-
-
0035312975
-
Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders
-
Aoki Y, Yarchoan R, Wyvill K, Okamoto S, Little RF, Tosato G. Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders. Blood. 2001;97 (7):2173-2176.
-
(2001)
Blood
, vol.97
, Issue.7
, pp. 2173-2176
-
-
Aoki, Y.1
Yarchoan, R.2
Wyvill, K.3
Okamoto, S.4
Little, R.F.5
Tosato, G.6
-
44
-
-
84861851475
-
HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice
-
Suthaus J, Stuhlmann-Laeisz C, Tompkins VS, et al. HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice. Blood. 2012;119 (22): 5173-5181.
-
(2012)
Blood
, vol.119
, Issue.22
, pp. 5173-5181
-
-
Suthaus, J.1
Stuhlmann-Laeisz, C.2
Tompkins, V.S.3
-
45
-
-
79959858676
-
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: A pilot study of virus-activated cytotoxic therapy
-
Uldrick TS, Polizzotto MN, Aleman K, et al. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy. Blood. 2011; 117 (26):6977-6986.
-
(2011)
Blood
, vol.117
, Issue.26
, pp. 6977-6986
-
-
Uldrick, T.S.1
Polizzotto, M.N.2
Aleman, K.3
-
46
-
-
78649480343
-
How i treat HIV-associated multicentric Castleman disease
-
Bower M. How I treat HIV-associated multicentric Castleman disease. Blood. 2010;116 (22): 4415-4421.
-
(2010)
Blood
, vol.116
, Issue.22
, pp. 4415-4421
-
-
Bower, M.1
-
47
-
-
34548232784
-
Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial
-
Gérard L, Bérezné A, Galicier L, et al. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial. J Clin Oncol. 2007;25 (22): 3350-3356.
-
(2007)
J Clin Oncol.
, vol.25
, Issue.22
, pp. 3350-3356
-
-
Gérard, L.1
Bérezné, A.2
Galicier, L.3
-
48
-
-
38449113389
-
Brief communication: Rituximab in HIV-associated multicentric Castleman disease
-
Bower M, Powles T, Williams S, et al. Brief communication: rituximab in HIV-associated multicentric Castleman disease. Ann Intern Med. 2007;147 (12):836-839.
-
(2007)
Ann Intern Med
, vol.147
, Issue.12
, pp. 836-839
-
-
Bower, M.1
Powles, T.2
Williams, S.3
-
49
-
-
77957283115
-
Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease
-
van Rhee F, Fayad L, Voorhees P, et al. Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease. J Clin Oncol. 2010;28 (23):3701-3708.
-
(2010)
J Clin Oncol
, vol.28
, Issue.23
, pp. 3701-3708
-
-
Van Rhee, F.1
Fayad, L.2
Voorhees, P.3
-
50
-
-
12344312699
-
-
U.S. Department of Health and Human Services.Bethesda,MD:DHHS;version 3.0 2006
-
U.S. Department of Health and Human Services. Common Toxicity Criteria For Adverse Events version 3.0. Bethesda, MD: DHHS; 2006
-
Common Toxicity Criteria For Adverse Events
-
-
-
51
-
-
85081803169
-
-
Meso-Scale Discovery. MSD Multiarray Proinflammatory 7-plex Assay and MSD Multiarray Singleplex IL-5 assay Product Insert. Gaithersburg, MD: Meso-Scale Discovery; 2010
-
Meso-Scale Discovery. MSD Multiarray Proinflammatory 7-plex Assay and MSD Multiarray Singleplex IL-5 assay Product Insert. Gaithersburg, MD: Meso-Scale Discovery; 2010
-
-
-
-
52
-
-
2342510407
-
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
-
Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113 (9): 1271-1276.
-
(2004)
J Clin Invest
, vol.113
, Issue.9
, pp. 1271-1276
-
-
Nemeth, E.1
Rivera, S.2
Gabayan, V.3
-
53
-
-
0025190892
-
Interleukin-6 and the acute phase response
-
Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990; 265 (3):621-636.
-
(1990)
Biochem J
, vol.265
, Issue.3
, pp. 621-636
-
-
Heinrich, P.C.1
Castell, J.V.2
Andus, T.3
-
54
-
-
0032933560
-
IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense
-
Steinhauser ML, Hogaboam CM, Kunkel SL, Lukacs NW, Strieter RM, Standiford TJ. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol. 1999; 162 (1):392-399.
-
(1999)
J Immunol
, vol.162
, Issue.1
, pp. 392-399
-
-
Steinhauser, M.L.1
Hogaboam, C.M.2
Kunkel, S.L.3
Lukacs, N.W.4
Strieter, R.M.5
Standiford, T.J.6
|